Captor Therapeutics (WAR:CTX) Price-to-Operating-Cash-Flow : (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-25), Captor Therapeutics's share price is zł76.00. Captor Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was zł-11.00. Hence, Captor Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Captor Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 7 years, Captor Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 149.63. The lowest was 0.00. And the median was 0.00.

WAR:CTX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Captor Therapeutics's Cash Flow from Operations per share for the three months ended in Dec. 2023 was zł-2.73. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was zł-11.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -291.10% per year.

During the past 7 years, Captor Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -115.40% per year. The lowest was -291.10% per year. And the median was -203.25% per year.

Captor Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Captor Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics Price-to-Operating-Cash-Flow Chart

Captor Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Captor Therapeutics Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Captor Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Captor Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Captor Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Captor Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Captor Therapeutics's Price-to-Operating-Cash-Flow falls into.

Captor Therapeutics Price-to-Operating-Cash-Flow Calculation

Captor Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	76.00	/	-11
	=

Captor Therapeutics's Share Price of today is zł76.00.
Captor Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-11.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Captor Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics (WAR:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

60Q:Germany

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.captortherapeutics.com

Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines